FDA- and EMA-Approved Tyrosine Kinase Inhibitors in Advanced <i>EGFR</i>-Mutated Non-Small Cell Lung Cancer: Safety, Tolerability, Plasma Concentration Monitoring, and Management

by Isabelle Solassol, Frédéric Pinguet, Xavier Quantin
Published 2019-10-01

Combination of tissue and liquid biopsy molecular profiling to detect transformation to small cell lung carcinoma during osimertinib treatment

by Julie A. Vendrell, Xavier Quantin, Isabelle Serre, Jérôme Solassol
Published 2020-12-01

Dissociated response related to corticosteroids in lung cancer treated by immunotherapy: A case report

by Quentin Dominique Thomas, Léa Sinoquet, Antonio Maraver, Xavier Quantin
Published 2021-05-01

Neutrophils in the era of immune checkpoint blockade

by Solange Peters, Nathalie Bonnefoy, Xavier Quantin, Julien Faget, Etienne Meylan
Published 2021-07-01

Executive Functions in Tobacco Dependence: Importance of Inhibitory Capacities.

by Valentin Flaudias, Marie Christine Picot, Jorge Lopez-Castroman, Pierre-Michel Llorca, Audrey Schmitt, Jean Perriot, Vera Georgescu, Philippe Courtet, Xavier Quantin, Sébastien Guillaume
Published 2016-01-01

Generation and Characterization of a New Preclinical Mouse Model of EGFR-Driven Lung Cancer with MET-Induced Osimertinib Resistance

by Maicol Mancini, Quentin-Dominique Thomas, Sylvia Bourdel, Laura Papon, Emilie Bousquet, Prisca Jalta, Silvia La Monica, Camille Travert, Roberta Alfieri, Xavier Quantin, Marta Cañamero, Antonio Maraver
Published 2021-07-01

Clinical efficacy and cost-effectiveness of endobronchial ultrasound-guided transbronchial needle aspiration for preoperative staging of non-small-cell lung cancer: Results of a Fr...

by Christos Chouaid, Mathieu Salaün, Valérie Gounant, Michel Febvre, Jean-Michel Vergnon, Vincent Jouniaux, Clément Fournier, Samy Lachkar, Christophe Hermant, Christophe Raspaud, Xavier Quantin, Jean-Jacques Quiot, Anita Molard, Charles Dayen, Charles-Hugo Marquette, Hervé Lena, Gérard Zalcman, Luc Thiberville
Published 2019-01-01